Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2026 May 22;82(Pt 6):702–706. doi: 10.1107/S2056989026004846

Synthesis and structure of 2-amino-4-methyl­pyridin-1-ium hippurate dihydrate

Vanitha Vetrivel a, Nishandhini Marimuthu b,*, Thangavelu Balakrishnan a,*
Editor: W T A Harrisonc
PMCID: PMC13239015  PMID: 42254772

In the title salt, the crystal structure features N—H⋯O and O—H⋯O hydrogen-bonding inter­actions, which link the components into infinite chains and generate an extended supra­molecular network.

Keywords: crystal structure, 2-amino-4-methyl­pyridin-1-ium cation, hippurate anion, Hirshfeld surface analysis

Abstract

In the extended structure of the title salt, C6H9N2+·C9H8NO3−·2H2O, the 2-amino-4-methyl­pyridin-1-ium cation and hippurate [or 2-(phenyl­formamido)­acetate] anion are linked through paired N—H⋯O hydrogen bonds, forming an R22(8) motif. The water mol­ecules of crystallization participate in O—H⋯O and N—H⋯O hydrogen-bonding inter­actions, which connect the mol­ecular components into one-dimensional chains that extend along the [010] direction. These inter­actions collectively generate a three-dimensional supra­molecular network.

1. Chemical context

Pyridinium-based organic salts continue to attract inter­est owing to their diverse supra­molecular architectures and their ability to form robust hydrogen-bonded networks in the solid state (Konovalova & Reiss, 2025 ▸; Bis & Zaworotko, 2005 ▸; Budzikur et al., 2022 ▸). 2-Amino-4-methyl­pyridine, C6H8N2, is a bi-functional heterocycle containing both a basic pyridine nitro­gen (ring N atom) and an exocyclic amino group (-NH2), enabling different hydrogen-bonding patterns and facilitating salt formation with a variety of organic acids. Protonated amino­pyridines are widely used as structure-directing cations because their multiple donor and acceptor sites support extended N—H⋯O, O—H⋯O, and π-associated supra­molecular motifs in the solid-state (Bedeković et al., 2017 ▸; Desiraju, 2002 ▸; Aakeröy & Seddon, 1993 ▸).

Hippuric acid (benzoyl­glycine, C9H9NO3) is a biologically relevant carb­oxy­lic acid that mimics short peptide fragments and provides several potential donor/acceptor sites through its carboxyl, amide, and aromatic groups (Li et al., 2024 ▸). Both hippuric acid and its deprotonated hippurate (benzoyl­glycinate, C9H8NO3−) anions are widely employed in organic salts and co-crystals, where their amide, carboxyl­ate, and aromatic functionalities enable complementary hydrogen-bonding inter­actions and π-stacking contacts (Laishram et al., 2025 ▸; Suganya et al., 2021 ▸).

Proton transfer in crystalline acid–base systems is commonly rationalized using the ΔpKa rule (Cruz-Cabeza, 2012 ▸, 2022 ▸): when the difference between the pKa of the conjugate acid of the base and the pKa of the acid exceeds ≃ 2–3, salt formation is favored. For the present system, the reported pKa values (hippuric acid ≃ 3.6 and 2-amino-4-methyl­pyridinium ion ≃ 7.5–8.1) gives ΔpKa ≃ 3.9, supporting proton transfer and the formation of a 2-amino-4-methyl­pyridinium benzoyl­glycinate salt. Such a proton transfer leads to the formation of charge-assisted N+—H⋯O hydrogen bonds, which are typically shorter, and more electrostatically strengthened than their neutral counterparts; these inter­actions often dominate the mol­ecular packing, enhance crystal cohesion and facilitate the incorporation of water mol­ecules of crystallization that further connect the ions through O—H⋯O and O—H⋯N hydrogen bonding.1.

As part of our studies in this area, we now describe the synthesis, structure and Hirshfeld surface analysis of the title hydrated salt, C6H9N2+·C9H8NO3−·2H2O (I).

2. Structural commentary

The hydrated title salt (I) was obtained by proton transfer from hippuric acid to 2-amino-4-methyl­pyridine in aqueous solution. The crystal structure unambiguously confirms salt formation through a proton-transfer reaction, which is consistent with the acidity constants of the components noted above, which strongly favors salt formation rather than co-crystallization

Compound (I) crystallizes as ortho­rhom­bic in space group Pbca. The asymmetric unit consists of one 2-amino-4-methyl­pyridin-1-ium cation, one hippurate anion and two water mol­ecules of crystallization, as illustrated in Fig. 1 ▸. In the cation, proton migration to the pyridine nitro­gen atom (N2) is further supported by the increase in the inter­nal angle around the protonated nitro­gen atom [C10—N2—C14 = 122.22 (13)°], compared with 117.3 (1)° in neutral 2-amino-4-methyl­pyridine (Kvick & Noordik, 1977 ▸). The bond lengths and angles of the cation closely resemble those observed in related structures, including 2-amino-4-methyl­pyridin-1-ium hydrogen squarate (Vetrivel et al., 2025 ▸) and other similar protonated analogues (Khalib et al., 2014 ▸). The non-hydrogen atoms of the cation are essentially planar, with a maximum deviation of 0.027 (3) Å for atom C15. In the hippurate anion, the carboxyl­ate group has nearly equivalent C—O bond lengths [O2—C9 = 1.2377 (18) Å and O3—C9 = 1.2598 (19) Å; Δ = 0.0221 Å], confirming deprotonation (Table 1 ▸). The key torsion angles for the side chain are C1—C7—N1—C8 = −175.96 (12)° and C7—N1—C8—C9 = −87.11 (18)° and the dihedral angle between the C1–C6 phenyl ring and the carboxyl­ate plane (O1/O2/C8/C9) is 70.96 (7)°. These geometric parameters are comparable to those reported for deprotonated hippurate anions in related crystal structures, such as cytosinium N-benzoyl­glycinate monohydrate (Görbitz & Sagstuen, 2004 ▸).

Figure 1.

Figure 1

The mol­ecular structure of the title salt, (I), showing the atom-labelling scheme. Displacement ellipsoids are drawn at the 50% probability level.

Table 1. Hydrogen-bond geometry (Å, °).

D—H⋯A D—H H⋯A D⋯A D—H⋯A
O5—H5A⋯O4 0.83 (2) 2.00 (2) 2.8225 (18) 167 (3)
N1—H1⋯O4i 0.85 (1) 2.25 (2) 2.9992 (18) 148 (2)
N2—H2A⋯O3ii 0.90 (2) 1.78 (2) 2.6850 (17) 176 (2)
N3—H3A⋯O2ii 0.89 (2) 1.99 (2) 2.8751 (17) 175 (2)
N3—H3B⋯O5iii 0.90 (2) 1.94 (2) 2.8368 (18) 171 (2)
O4—H4A⋯O3iv 0.88 (2) 1.88 (2) 2.7392 (17) 166 (2)
O4—H4B⋯O1v 0.87 (2) 1.95 (2) 2.8173 (18) 173 (2)
O5—H5B⋯O2i 0.88 (2) 1.94 (2) 2.8061 (18) 170 (3)

Symmetry codes: (i) Inline graphic; (ii) Inline graphic; (iii) Inline graphic; (iv) Inline graphic; (v) Inline graphic.

3. Supra­molecular features

In the extended structure, the cation and anion are connected through N2—H2A⋯O3 and N3—H3A⋯O2 hydrogen bonds (Table 1 ▸, Fig. 2 ▸), generating an Inline graphic (8) motif. The two water mol­ecules of crystallization participate actively in the hydrogen-bonding network. In particular, a O5—H5A⋯O4 hydrogen bond links the two water mol­ecules. All the oxygen atoms of the anion (O1–O3), together with the water O atoms (O4 and O5), function as hydrogen-bond acceptors in various inter­molecular N—H⋯O and O—H⋯O inter­actions (Table 1 ▸).

Figure 2.

Figure 2

(a) Part of the crystal structure of (I) showing the Inline graphic(8) motif formed by inter­molecular N—H⋯O hydrogen bonds. (b) The N1—H1⋯O4 and O4—H4B⋯O1 hydrogen bonds connect neighbouring hippurate anions and water mol­ecule O4 (water – 1), forming a one-dimensional chains runs along the [010] direction. (c) The O4—H4A⋯O3, N1—H1⋯O4 and O4—H4B⋯O1 hydrogen bonds generate an Inline graphic (16) motif, resulting in a supra­molecular ladder-like arrangement running parallel to [010].

The N1—H1⋯O4 and O4—H4B⋯O1 hydrogen bonds connect neighbouring hippurate anions and water mol­ecule (water-1, O4), forming four-membered units that propagate into a one dimensional chains extending along the [010] direction. Furthermore, the O4—H4A⋯O3 hydrogen bond along with the N1—H1⋯O4 and O4—H4B⋯O1 hydrogen bonds, generates an Inline graphic (16) loop, resulting in a supra­molecular ladder-like arrangement running parallel to [010]. This ladder is further reinforced by hydrogen bonding involving the cation, namely N2—H2A⋯O3, N3—H3A⋯O2 and O5—H5B⋯O2 and N3—H3B···O5, which link the second water mol­ecule (water-2, O5) to the cationic fragment. Collectively, the hydrogen bonds inter­connect the cations, anions, and water mol­ecules of crystallization into a three-dimensional supra­molecular network (Figs. 3 ▸ and 4 ▸).

Figure 3.

Figure 3

Overall crystal packing of the title salt (I), viewed down the a axis. Hydrogen atoms have been omitted for clarity.

Figure 4.

Figure 4

Two views of the Hirshfeld surfaces of the cation, anion and water molecules of crystallization in the title salt (I), mapped over dnorm and the shape-index surface.

4. Hirshfeld surface analysis

Hirshfeld surface (HS) analysis was carried out using CrystalExplorer 21.5 (Turner et al., 2017 ▸). The front and back views of the HS mapped over dnorm for the asymmetric unit are shown in Fig. 4 ▸, together with the individual surfaces for the cation, anion and the two water mol­ecules. Bright-red spots on the dnorm-mapped surfaces correspond to close contacts, i.e., inter­molecular distances shorter than the sum of the van der Waals radii, and thus indicate significant non-covalent inter­actions. In contrast, the shape-index surface does not exhibit complementary red and blue triangular features, indicating the absence of significant π–π stacking inter­actions in (I).

The full and decomposed two-dimensional fingerprint plots for the cation, anion and the water mol­ecules are presented in Fig. 5 ▸. The H⋯H contacts make the largest contribution for both the cation (50.1%) and the anion (47.1%), and also account for significant contributions in water-1 (40.6%) and water-2 (46.5%). For the water mol­ecules, O⋯H/H⋯O contacts are particularly prominent, reflecting their active participation in O—H⋯O hydrogen bonds. The sharp spikes observed in the FP plots at de + di = 1.6–1.8 Å for O⋯H/H⋯O contacts are characteristic of strong N/O—H⋯O hydrogen bonds (Table 1 ▸). The C⋯H/H⋯C inter­actions represent the next significant contribution in the cation (18.5%) and anion (12.8%). The remaining contacts, namely N⋯H/H⋯N, C⋯N and C⋯C, contribute comparatively less to the total Hirshfeld surface area. Although both water mol­ecules participate in O—H⋯O hydrogen bonding, their relative percentage contributions and hydrogen-bond geometries indicate subtle differences in their inter­action environments within the crystal.

Figure 5.

Figure 5

Full and decomposed two-dimensional fingerprint (FP) plots for the cation, anion and the two water molecules of crystallization in the title salt (I), showing the different inter­molecular contacts and their percentage contributions.

5. Database survey

A search of the Cambridge Structural Database (CSD, Version 6.01, updated of November 2025; (Groom et al., 2016 ▸) performed using Conquest (Bruno et al., 2002 ▸) for the 2-amino-4-methyl­pyridin-1-ium cation yielded 62 entries corresponding to salt forms. A number of these salts are with substituted benzoic acids such as 2-hy­droxy­benzoic acid (CSD refcode DUTZOI) and 3-hy­droxy­benzoic acid (AGAQIK) (Khalib et al., 2013 ▸), 2- and 4-chloro­benzoic acids (COZVAQ and COZVOE); 4-methyl­benzoic acid (COZVIY) (Khalib et al., 2014 ▸); and 4-nitro­benzoic acid (DUNCOF; Hemamalini & Fun, 2010a ▸), as well as other related substituted benzoates.

Salts with aliphatic carb­oxy­lic acids have also been reported, including succinic acid (DICYEW; Seth et al., 2018 ▸), fumaric acid (DUSPUD; Hemamalini & Fun, 2010c ▸), tri­fluoro­acetic acid (KUSVAW; Hemamalini & Fun, 2010b ▸), sorbic acid (SUZXUH; Hemamalini & Fun, 2010d ▸), oxalic acid (YIZDAQ; Hemalatha et al., 2023 ▸) and tartaric acid (YOHHIO; Jovita et al., 2014 ▸).

A separate search for the hippurate anion revealed eight structures in the CSD. These correspond to salts of hippuric acid with various active pharmaceutical ingredients (APIs) and biologically relevant bases, including imatinib (AJIPOC) (Jiang et al., 2025 ▸); ciprofloxacin (OSUQEA; Chadha et al., 2016 ▸); cytosine (CYTBGL01); Görbitz & Sagstuen, 2004 ▸) guanidine (BEMWOJ; Reena et al., 2022 ▸) and acridine (XANSOY; Suganya et al., 2021 ▸). These results indicate that, although salts of the individual components are well documented in the structural database, structures comprising both components in a single salt are comparatively uncommon. The available entries further underscore the conformational flexibility and supra­molecular versatility of the hippurate anion, which consistently assembles into stable crystal architectures primarily via classical N—H⋯O and O—H⋯O hydrogen-bonding inter­actions.

6. Synthesis and crystallization

Hot methanol solutions (50 mL) of 2-amino-4-methyl­pyridine (1.08 g, 1.00 mmol) and hippuric acid (1.80 g, 1.00 mmol) were mixed and warmed over a heating magnetic stirrer hotplate for 6h. The reaction mixture was stirred at room temperature for 6 h to obtain a clear homogeneous solution. The resulting solution was filtered and allowed to evaporate slowly at room temperature. Colourless block-shaped crystals suitable for single-crystal X-ray diffraction were obtained after approximately 10 days.

7. Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. H atoms were positioned geometrically (C—H = 0.93–0.96 Å) and refined as riding with Uiso(H) = 1.2Ueq(C).

Table 2. Experimental details.

Crystal data
Chemical formula C6H9N2+·C9H8NO3−·2(H2O)
M r 323.35
Crystal system, space group Orthorhombic, Pbca
Temperature (K) 298
a, b, c (Å) 15.137 (3), 7.3028 (14), 30.583 (6)
V (Å3) 3380.7 (11)
Z 8
Radiation type Cu Kα
μ (mm−1) 0.81
Crystal size (mm) 0.35 × 0.24 × 0.22
 
Data collection
Diffractometer Bruker D8 Venture Diffractometer
Absorption correction Multi-scan (SADABS; Krause et al., 2015 ▸)
Tmin, Tmax 0.547, 0.753
No. of measured, independent and observed [I > 2σ(I)] reflections 24560, 3208, 2918
R int 0.051
(sin θ/λ)max (Å−1) 0.610
 
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.053, 0.153, 1.09
No. of reflections 3208
No. of parameters 234
No. of restraints 8
H-atom treatment H atoms treated by a mixture of independent and constrained refinement
Δρmax, Δρmin (e Å−3) 0.20, −0.20

Computer programs: APEX4, SAINT and XPREP (Bruker, 2021 ▸), SHELXT2014/5 (Sheldrick, 2015a ▸), SHELXL2014/3 (Sheldrick, 2015b ▸), ORTEP-3 for Windows (Farrugia, 2012 ▸), Mercury (Macrae et al., 2020 ▸) and PLATON (Spek, 2020 ▸).

Supplementary Material

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989026004846/hb8212sup1.cif

e-82-00702-sup1.cif (784.1KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989026004846/hb8212Isup2.hkl

e-82-00702-Isup2.hkl (256.6KB, hkl)
e-82-00702-Isup3.cml (6.3KB, cml)

Supporting information file. DOI: 10.1107/S2056989026004846/hb8212Isup3.cml

CCDC reference: 2552915

Additional supporting information: crystallographic information; 3D view; checkCIF report

Acknowledgments

The authors gratefully acknowledge SAIF, IIT Madras, for the SCXRD data collection.

supplementary crystallographic information

2-Amino-4-methylpyridin-1-ium 2-(phenylformamido)acetate dihydrate. Crystal data

C6H9N2+·C9H8NO3−·2(H2O) Dx = 1.271 Mg m−3
Mr = 323.35 Cu Kα radiation, λ = 1.54178 Å
Orthorhombic, Pbca Cell parameters from 7667 reflections
a = 15.137 (3) Å θ = 4.1–70.0°
b = 7.3028 (14) Å µ = 0.81 mm−1
c = 30.583 (6) Å T = 298 K
V = 3380.7 (11) Å3 Block, colourless
Z = 8 0.35 × 0.24 × 0.22 mm
F(000) = 1376

2-Amino-4-methylpyridin-1-ium 2-(phenylformamido)acetate dihydrate. Data collection

Bruker D8 Venture Diffractometer 2918 reflections with I > 2σ(I)
Radiation source: micro focus sealed tube Rint = 0.051
φ and ω scans θmax = 70.0°, θmin = 2.9°
Absorption correction: multi-scan (SADABS; Krause et al., 2015) h = −18→18
Tmin = 0.547, Tmax = 0.753 k = −8→8
24560 measured reflections l = −34→37
3208 independent reflections

2-Amino-4-methylpyridin-1-ium 2-(phenylformamido)acetate dihydrate. Refinement

Refinement on F2 Hydrogen site location: mixed
Least-squares matrix: full H atoms treated by a mixture of independent and constrained refinement
R[F2 > 2σ(F2)] = 0.053 w = 1/[σ2(Fo2) + (0.0923P)2 + 0.350P] where P = (Fo2 + 2Fc2)/3
wR(F2) = 0.153 (Δ/σ)max = 0.001
S = 1.09 Δρmax = 0.20 e Å−3
3208 reflections Δρmin = −0.19 e Å−3
234 parameters Extinction correction: SHELXL2019/2 (Sheldrick 2015b), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
8 restraints Extinction coefficient: 0.0072 (6)

2-Amino-4-methylpyridin-1-ium 2-(phenylformamido)acetate dihydrate. Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

2-Amino-4-methylpyridin-1-ium 2-(phenylformamido)acetate dihydrate. Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
C1 0.52405 (11) 0.6531 (2) 0.55085 (5) 0.0634 (4)
C2 0.57345 (12) 0.5010 (3) 0.56117 (6) 0.0820 (5)
H2 0.553559 0.420177 0.582510 0.098*
C3 0.65265 (14) 0.4676 (3) 0.53993 (7) 0.0976 (6)
H3 0.685875 0.364962 0.547277 0.117*
C4 0.68232 (13) 0.5843 (4) 0.50824 (6) 0.0949 (6)
H4 0.735675 0.561428 0.494186 0.114*
C5 0.63421 (17) 0.7325 (4) 0.49740 (7) 0.0992 (7)
H5 0.654065 0.811233 0.475605 0.119*
C6 0.55571 (15) 0.7679 (3) 0.51848 (7) 0.0886 (5)
H6 0.523277 0.871148 0.510788 0.106*
C7 0.43806 (12) 0.6994 (2) 0.57182 (5) 0.0653 (4)
C8 0.30803 (10) 0.5937 (2) 0.61047 (5) 0.0666 (4)
H8A 0.275980 0.478744 0.609411 0.080*
H8B 0.276331 0.680558 0.592319 0.080*
C9 0.30683 (10) 0.6635 (2) 0.65749 (5) 0.0614 (4)
C10 0.22844 (9) 0.12490 (18) 0.27751 (4) 0.0547 (3)
C11 0.24565 (10) 0.05872 (18) 0.32012 (4) 0.0588 (4)
H11 0.198861 0.022428 0.337826 0.071*
C12 0.32969 (10) 0.0475 (2) 0.33553 (5) 0.0636 (4)
C13 0.40030 (11) 0.1037 (3) 0.30865 (6) 0.0742 (4)
H13 0.458206 0.099824 0.318772 0.089*
C14 0.38185 (11) 0.1635 (3) 0.26776 (6) 0.0743 (5)
H14 0.427978 0.199248 0.249575 0.089*
C15 0.34820 (14) −0.0249 (3) 0.38085 (6) 0.0892 (6)
H15A 0.365066 0.074466 0.399619 0.134*
H15B 0.395280 −0.112843 0.379533 0.134*
H15C 0.296011 −0.082495 0.392225 0.134*
N1 0.39430 (9) 0.56514 (17) 0.59169 (4) 0.0621 (3)
H1 0.4169 (11) 0.458 (2) 0.5917 (6) 0.074*
N2 0.29813 (8) 0.17252 (17) 0.25277 (4) 0.0623 (3)
H2A 0.2858 (11) 0.212 (2) 0.2254 (5) 0.075*
N3 0.14821 (9) 0.1412 (2) 0.26100 (4) 0.0677 (4)
O1 0.40736 (11) 0.85655 (16) 0.56980 (5) 0.0929 (4)
O2 0.37639 (8) 0.67686 (18) 0.67853 (4) 0.0767 (4)
O3 0.23079 (7) 0.70195 (18) 0.67150 (4) 0.0753 (4)
H3A 0.1393 (13) 0.192 (3) 0.2350 (5) 0.090*
H3B 0.1007 (11) 0.123 (3) 0.2784 (6) 0.090*
O4 0.58180 (8) 0.82361 (16) 0.37897 (4) 0.0752 (4)
H4A 0.6302 (14) 0.835 (3) 0.3632 (7) 0.113*
H4B 0.5816 (16) 0.926 (3) 0.3936 (8) 0.113*
O5 0.48776 (8) 0.5845 (2) 0.32339 (4) 0.0810 (4)
H5A 0.5105 (18) 0.668 (3) 0.3383 (9) 0.122*
H5B 0.5277 (16) 0.498 (3) 0.3257 (9) 0.122*

2-Amino-4-methylpyridin-1-ium 2-(phenylformamido)acetate dihydrate. Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
C1 0.0790 (9) 0.0570 (8) 0.0541 (7) −0.0026 (6) −0.0060 (6) −0.0066 (6)
C2 0.0823 (11) 0.0888 (12) 0.0747 (10) 0.0142 (9) 0.0078 (8) 0.0155 (9)
C3 0.0814 (11) 0.1203 (17) 0.0911 (13) 0.0221 (11) 0.0085 (10) 0.0122 (12)
C4 0.0799 (11) 0.1351 (19) 0.0696 (10) −0.0122 (12) 0.0047 (8) −0.0119 (11)
C5 0.1157 (16) 0.1059 (16) 0.0761 (11) −0.0271 (14) 0.0145 (11) 0.0030 (11)
C6 0.1159 (15) 0.0685 (10) 0.0816 (11) −0.0032 (10) 0.0058 (10) 0.0065 (9)
C7 0.0876 (10) 0.0498 (8) 0.0586 (8) 0.0082 (7) −0.0076 (7) −0.0093 (6)
C8 0.0699 (9) 0.0698 (9) 0.0602 (8) 0.0084 (7) −0.0062 (6) −0.0154 (7)
C9 0.0645 (8) 0.0597 (8) 0.0600 (8) 0.0067 (6) −0.0044 (6) −0.0096 (6)
C10 0.0623 (8) 0.0475 (7) 0.0544 (7) 0.0030 (5) 0.0057 (5) −0.0001 (5)
C11 0.0690 (8) 0.0530 (7) 0.0544 (7) 0.0020 (6) 0.0067 (6) 0.0014 (5)
C12 0.0738 (9) 0.0575 (8) 0.0595 (8) 0.0052 (6) −0.0026 (6) −0.0039 (6)
C13 0.0642 (8) 0.0820 (11) 0.0765 (10) 0.0032 (7) −0.0022 (7) 0.0011 (8)
C14 0.0621 (8) 0.0838 (11) 0.0770 (10) −0.0003 (7) 0.0113 (7) 0.0041 (8)
C15 0.0932 (12) 0.1075 (14) 0.0669 (10) 0.0085 (11) −0.0128 (9) 0.0097 (9)
N1 0.0744 (8) 0.0522 (6) 0.0596 (7) 0.0106 (5) −0.0007 (5) −0.0081 (5)
N2 0.0652 (7) 0.0642 (7) 0.0574 (7) 0.0041 (5) 0.0092 (5) 0.0053 (5)
N3 0.0623 (7) 0.0802 (9) 0.0607 (7) 0.0035 (6) 0.0047 (5) 0.0136 (6)
O1 0.1266 (11) 0.0521 (7) 0.1000 (9) 0.0204 (6) 0.0054 (8) −0.0046 (6)
O2 0.0679 (7) 0.0963 (8) 0.0658 (6) 0.0137 (5) −0.0098 (5) −0.0226 (5)
O3 0.0647 (7) 0.0951 (8) 0.0660 (6) 0.0101 (5) −0.0031 (5) −0.0206 (6)
O4 0.0689 (7) 0.0668 (7) 0.0900 (8) −0.0026 (5) 0.0090 (6) −0.0152 (6)
O5 0.0726 (7) 0.0918 (9) 0.0787 (8) 0.0119 (6) −0.0210 (6) −0.0044 (6)

2-Amino-4-methylpyridin-1-ium 2-(phenylformamido)acetate dihydrate. Geometric parameters (Å, º)

C1—C2 1.376 (2) C10—N2 1.3439 (18)
C1—C6 1.383 (3) C10—C11 1.4142 (19)
C1—C7 1.490 (2) C11—C12 1.359 (2)
C2—C3 1.385 (3) C11—H11 0.9300
C2—H2 0.9300 C12—C13 1.409 (2)
C3—C4 1.367 (3) C12—C15 1.510 (2)
C3—H3 0.9300 C13—C14 1.354 (3)
C4—C5 1.346 (3) C13—H13 0.9300
C4—H4 0.9300 C14—N2 1.349 (2)
C5—C6 1.376 (3) C14—H14 0.9300
C5—H5 0.9300 C15—H15A 0.9600
C6—H6 0.9300 C15—H15B 0.9600
C7—O1 1.2394 (19) C15—H15C 0.9600
C7—N1 1.330 (2) N1—H1 0.851 (14)
C8—N1 1.442 (2) N2—H2A 0.904 (15)
C8—C9 1.526 (2) N3—H3A 0.888 (15)
C8—H8A 0.9700 N3—H3B 0.903 (15)
C8—H8B 0.9700 O4—H4A 0.881 (17)
C9—O2 1.2377 (18) O4—H4B 0.872 (17)
C9—O3 1.2598 (19) O5—H5A 0.834 (17)
C10—N3 1.3205 (19) O5—H5B 0.879 (17)
C2—C1—C6 117.73 (17) N3—C10—C11 123.54 (13)
C2—C1—C7 124.01 (14) N2—C10—C11 117.56 (13)
C6—C1—C7 118.25 (15) C12—C11—C10 120.83 (13)
C1—C2—C3 120.33 (18) C12—C11—H11 119.6
C1—C2—H2 119.8 C10—C11—H11 119.6
C3—C2—H2 119.8 C11—C12—C13 119.33 (14)
C4—C3—C2 120.5 (2) C11—C12—C15 120.87 (15)
C4—C3—H3 119.8 C13—C12—C15 119.79 (16)
C2—C3—H3 119.8 C14—C13—C12 118.45 (16)
C5—C4—C3 119.9 (2) C14—C13—H13 120.8
C5—C4—H4 120.0 C12—C13—H13 120.8
C3—C4—H4 120.0 N2—C14—C13 121.56 (15)
C4—C5—C6 120.2 (2) N2—C14—H14 119.2
C4—C5—H5 119.9 C13—C14—H14 119.2
C6—C5—H5 119.9 C12—C15—H15A 109.5
C5—C6—C1 121.4 (2) C12—C15—H15B 109.5
C5—C6—H6 119.3 H15A—C15—H15B 109.5
C1—C6—H6 119.3 C12—C15—H15C 109.5
O1—C7—N1 121.22 (17) H15A—C15—H15C 109.5
O1—C7—C1 121.09 (16) H15B—C15—H15C 109.5
N1—C7—C1 117.66 (13) C7—N1—C8 121.76 (13)
N1—C8—C9 115.75 (12) C7—N1—H1 118.4 (13)
N1—C8—H8A 108.3 C8—N1—H1 119.7 (13)
C9—C8—H8A 108.3 C10—N2—C14 122.22 (13)
N1—C8—H8B 108.3 C10—N2—H2A 116.2 (11)
C9—C8—H8B 108.3 C14—N2—H2A 121.6 (11)
H8A—C8—H8B 107.4 C10—N3—H3A 121.3 (13)
O2—C9—O3 125.66 (13) C10—N3—H3B 119.6 (13)
O2—C9—C8 120.40 (13) H3A—N3—H3B 117.8 (19)
O3—C9—C8 113.94 (13) H4A—O4—H4B 102 (2)
N3—C10—N2 118.90 (13) H5A—O5—H5B 101 (3)
C6—C1—C2—C3 0.9 (3) N3—C10—C11—C12 −179.07 (14)
C7—C1—C2—C3 179.70 (18) N2—C10—C11—C12 1.2 (2)
C1—C2—C3—C4 −0.6 (3) C10—C11—C12—C13 0.4 (2)
C2—C3—C4—C5 −0.3 (3) C10—C11—C12—C15 −179.38 (15)
C3—C4—C5—C6 0.7 (3) C11—C12—C13—C14 −1.5 (2)
C4—C5—C6—C1 −0.4 (3) C15—C12—C13—C14 178.29 (17)
C2—C1—C6—C5 −0.5 (3) C12—C13—C14—N2 1.0 (3)
C7—C1—C6—C5 −179.33 (17) O1—C7—N1—C8 2.2 (2)
C2—C1—C7—O1 161.68 (17) C1—C7—N1—C8 −175.96 (12)
C6—C1—C7—O1 −19.5 (2) C9—C8—N1—C7 −87.11 (18)
C2—C1—C7—N1 −20.2 (2) N3—C10—N2—C14 178.47 (15)
C6—C1—C7—N1 158.64 (15) C11—C10—N2—C14 −1.8 (2)
N1—C8—C9—O2 −6.4 (2) C13—C14—N2—C10 0.7 (3)
N1—C8—C9—O3 174.15 (14)

2-Amino-4-methylpyridin-1-ium 2-(phenylformamido)acetate dihydrate. Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
O5—H5A···O4 0.83 (2) 2.00 (2) 2.8225 (18) 167 (3)
N1—H1···O4i 0.85 (1) 2.25 (2) 2.9992 (18) 148 (2)
N2—H2A···O3ii 0.90 (2) 1.78 (2) 2.6850 (17) 176 (2)
N3—H3A···O2ii 0.89 (2) 1.99 (2) 2.8751 (17) 175 (2)
N3—H3B···O5iii 0.90 (2) 1.94 (2) 2.8368 (18) 171 (2)
O4—H4A···O3iv 0.88 (2) 1.88 (2) 2.7392 (17) 166 (2)
O4—H4B···O1v 0.87 (2) 1.95 (2) 2.8173 (18) 173 (2)
O5—H5B···O2i 0.88 (2) 1.94 (2) 2.8061 (18) 170 (3)

Symmetry codes: (i) −x+1, −y+1, −z+1; (ii) −x+1/2, −y+1, z−1/2; (iii) −x+1/2, y−1/2, z; (iv) x+1/2, −y+3/2, −z+1; (v) −x+1, −y+2, −z+1.

References

  1. Aakeröy, C. B. & Seddon, K. R. (1993). Chem. Soc. Rev.22, 397–407.
  2. Bedeković, N., Stilinović, V. & Piteša, T. (2017). Cryst. Growth Des.17, 5732–5743. [DOI] [PMC free article] [PubMed]
  3. Bis, J. A. & Zaworotko, M. J. (2005). Cryst. Growth Des.5, 1169–1179.
  4. Bruker (2021). APEX4, SAINT and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA.
  5. Bruno, I. J., Cole, J. C., Edgington, P. R., Kessler, M., Macrae, C. F., McCabe, P., Pearson, J. & Taylor, R. (2002). Acta Cryst. B58, 389–397. [DOI] [PubMed]
  6. Budzikur, D., Kinzhybalo, V. & Ślepokura, K. (2022). CrystEngComm24, 4417–4429.
  7. Chadha, R., Singh, P., Khullar, S. & Mandal, S. K. (2016). Cryst. Growth Des.16, 4960–4967.
  8. Cruz-Cabeza, A. J. (2012). CrystEngComm14, 6362–6365.
  9. Cruz-Cabeza, A. J., Lusi, M., Wheatcroft, H. P. & Bond, A. D. (2022). Faraday Discuss.235, 446–466. [DOI] [PubMed]
  10. Desiraju, G. R. (2002). Acc. Chem. Res.35, 565–573. [DOI] [PubMed]
  11. Farrugia, L. J. (2012). J. Appl. Cryst.45, 849–854.
  12. Görbitz, C. H. & Sagstuen, E. (2004). Acta Cryst. E60, o1945–o1947.
  13. Groom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171–179. [DOI] [PMC free article] [PubMed]
  14. Hemalatha, B., Suresh, S. & Poomani, K. (2023). Chem. Data Collect. 48, 101100.
  15. Hemamalini, M. & Fun, H.-K. (2010a). Acta Cryst. E66, o335. [DOI] [PMC free article] [PubMed]
  16. Hemamalini, M. & Fun, H.-K. (2010b). Acta Cryst. E66, o781–o782. [DOI] [PMC free article] [PubMed]
  17. Hemamalini, M. & Fun, H.-K. (2010c). Acta Cryst. E66, o1962–o1963. [DOI] [PMC free article] [PubMed]
  18. Hemamalini, M. & Fun, H.-K. (2010d). Acta Cryst. E66, o2397–o2398. [DOI] [PMC free article] [PubMed]
  19. Jiang, Q., Ghosh, R. K., Valdivia-Berroeta, G. A., Walder, B. J. & Luo, L. (2025). Cryst. Growth Des.25, 1978–1991.
  20. Jovita, J. V., Sathya, S., Usha, G., Vasanthi, R. & Ramanand, A. (2014). Acta Cryst. E70, o1036–o1037. [DOI] [PMC free article] [PubMed]
  21. Khalib, N. C., Thanigaimani, K., Arshad, S. & Razak, I. A. (2013). Acta Cryst. E69, o1120. [DOI] [PMC free article] [PubMed]
  22. Khalib, N. C., Thanigaimani, K., Arshad, S. & Razak, I. A. (2014). J. Chem. Crystallogr.44, 555–571.
  23. Konovalova, I. S. & Reiss, G. J. (2025). Crystals15, 700.
  24. Krause, L., Herbst-Irmer, R., Sheldrick, G. M. & Stalke, D. (2015). J. Appl. Cryst.48, 3–10. [DOI] [PMC free article] [PubMed]
  25. Kvick, Å. & Noordik, J. (1977). Acta Cryst. B33, 2862–2866.
  26. Laishram, R., Singh, A. R., Devi, S. S., Thomson, N., Chanu, W. P., Sieroń, L., Maniukiewicz, W. & Lonibala, R. (2025). Polyhedron280, 117682.
  27. Li, W., Dong, H., Niu, K., Wang, H.-Y., Cheng, W., Song, H., Ying, A.-K., Zhai, X., Li, K., Yu, H., Guo, D.-S. & Wang, Y. (2024). Talanta278, 126480. [DOI] [PubMed]
  28. Macrae, C. F., Sovago, I., Cottrell, S. J., Galek, P. T. A., McCabe, P., Pidcock, E., Platings, M., Shields, G. P., Stevens, J. S., Towler, M. & Wood, P. A. (2020). J. Appl. Cryst.53, 226–235. [DOI] [PMC free article] [PubMed]
  29. Reena, P., Joema, S. E., Gunasekaran, B., Sindhusha, S., Sabari Girisun, T. C. & Darling, D. A. (2022). Opt. Mater.132, 112749.
  30. Seth, S. K., Bauzá, A. & Frontera, A. (2018). New J. Chem.42, 12134–12142.
  31. Sheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.
  32. Sheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.
  33. Spek, A. L. (2020). Acta Cryst. E76, 1–11. [DOI] [PMC free article] [PubMed]
  34. Suganya, S., Saravanan, K., Jaganathan, R. & Kumaradhas, P. (2021). Acta Cryst. C77, 790–799. [DOI] [PubMed]
  35. Turner, M., McKinnon, J., Wolff, S., Grimwood, D., Spackman, P., Jayatilaka, D. & Spackman, M. (2017). University of Western Australia.
  36. Vetrivel, V., Balakrishnan, T. & Marimuthu, N. (2025). Acta Cryst. E81, 1189–1194. [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989026004846/hb8212sup1.cif

e-82-00702-sup1.cif (784.1KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989026004846/hb8212Isup2.hkl

e-82-00702-Isup2.hkl (256.6KB, hkl)
e-82-00702-Isup3.cml (6.3KB, cml)

Supporting information file. DOI: 10.1107/S2056989026004846/hb8212Isup3.cml

CCDC reference: 2552915

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES